MAT Tools and Resources

This tool highlights another valuable method for health departments to ensure the inclusion of People With Lived or Living Experience (PWLLE): establishing grantmaking programs and developing meaningful partnerships with community-based organizations (CBOs) that are led for and by PWLLE, including harm reduction organizations.

This tool highlights examples of successful People With Lived and Living Experience (PWLLE) engagement in data collection, interpretation and dissemination, gathered through key informant interviews — including overdose fatality review committees, drug checking, patient surveys and overdose reversal reporting — as well as novel approaches to community-based participatory research.

This tool identifies key elements for health departments to consider when hiring People With Lived and Living Experience (PWLLE), from identification and description of job roles and responsibilities to recruitment and interviewing.

This resource presents information gleaned from an environmental scan and a series of key infomant interviews to identify ways in which health departments can meaningfully involve people with lived and/or living experience (PWLLE) in overdose surveillance and prevention.

The article discusses the new FDA approval for the first nalmefene hydrochloride auto-injector for emergent treatment of a suspected opioid overdose.

The findings from this Issue Brief reveal notable gaps in integrated SUD and mental health services, inpatient and residential care capacity, and use of medications for SUD treatment, with substantial variation across states and territories.

This toolkit provides resources to teach people about how to support those in recovery. It also provides materials intented for promoting recovery month awareness.

The article reviews the role that telehealth can play in providing medications for opioid use disorder (MOUD) treatment.

This Advisory reviews the evidence on prescription stimulant misuse among youth and young adults. It establishes prescription stimulant misuse as a public health problem, identifies associated risk and protective factors, and provides programs and action steps for stakeholders to prevent misuse.

This guide reviews evidence related to leveraging community engagement to support the implementation and scale-up of evidence-based programs and policies.